This is thanks to its active ingredient, orforglipron , which is a non-peptide
Monitor blood sugar, weight loss progress, and any side effects, particularly gastrointestinal symptoms
Approximately 15% to 20% of participants achieved greater than 30% weight loss
By injecting a small dose of prescribed Semaglutide GLP-1 into the upper arm, thigh, or abdomen, patients have reported themselves better at resisting their cravings, feeling satiated for longer periods of time, and that their energy levels feel more stable throughout the day
J Med Chem 58(18):73707380
The two primary endpoints were the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS, which ranges from 0 to 100) and the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS)